Roche Forecasts 2026 Growth, Cites Drug-Pipeline Strength

Date:




The Swiss drugmaker expects sales and core earnings per share to grow at constant currencies this year, partly due to the strength of its drug pipeline.



Source link

Share post:

Subscribe

spot_imgspot_img

Popular

More like this
Related

Uber’s $11.6 Billion Takeover Approach Lifts Delivery Hero Shares

Uber has emerged as the biggest shareholder in Delivery...

Victor Wembanyama sets tone in Game 4 as Spurs even series

Michael C. WrightMay 24, 2026, 11:13 PM ETCloseJoined ESPN...